Publications by authors named "Andrea Toja"

Claim this Profile
C
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.
Giovanni Bellomo, Andrea Toja, Lorenzo Gaetani, Giovanna Nardi, Federico Paolini Paoletti

Neurobiol Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease.
Giovanni Bellomo, Federico Paolini Paoletti, Lorenzo Gaetani, Andrea Toja, Yihua Ma

J Parkinsons Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.
James D Doecke, Giovanni Bellomo, Lisa Vermunt, Daniel Alcolea, Steffen Halbgebauer, Andrea Toja

Alzheimers Dement· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment.
Katharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, Alberto Rábano, Minerva Martínez, Andrea Toja

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease.
Nerea Gómez de San José, Steffen Halbgebauer, Petra Steinacker, Sarah Anderl-Straub, Samir Abu-Rumeileh, Andrea Toja

Transl Neurodegener· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay.
Giovanni Bellomo, Andrea Toja, Federico Paolini Paoletti, Yihua Ma, Carly M Farris

Alzheimers Dement· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
Giovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, Andrea Toja, Giovanna Nardi

Alzheimers Dement· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa assays targeting distinct amyloid regions.
Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, Lorenzo Gaetani, Lucilla Parnetti

Clin Chem Lab Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP.
Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani, Andrea Toja, Elena Chipi

Neurobiol Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum.
Silvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, Elena Chipi

Alzheimers Res Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers.
Lucia Farotti, Federica Nicoletta Sepe, Andrea Toja, Roberta Rinaldi, Lucilla Parnetti

Clin Biochem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis